Entecavir is primarily approved for the treatment of chronic hepatitis B virus infection in adults and pediatric patients. It is used in patients with active viral replication and evidence of liver inflammation or damage. Entecavir is often prescribed as a long-term therapy to reduce viral load, prevent disease progression, and lower the risk of complications such as cirrhosis and liver cancer. It plays an important role in maintaining liver health in patients with chronic HBV infection.

Entecavir works by inhibiting the hepatitis B virus DNA polymerase enzyme, which is essential for viral replication. It interferes with multiple steps in the viral replication process, including base priming, reverse transcription, and DNA synthesis. By blocking these processes, entecavir effectively reduces the amount of virus in the body. This helps slow disease progression, reduce liver inflammation, and improve overall liver function.

Entecavir is administered orally in tablet or solution form, usually taken once daily. It is recommended to take the medication on an empty stomach, at least two hours before or after a meal, to ensure optimal absorption. The dosage may vary depending on the patient’s condition, treatment history, and kidney function. Long-term adherence to therapy is essential for maintaining viral suppression and preventing resistance. Regular monitoring through blood tests is required to assess treatment response.

Entecavir is generally well tolerated, but some patients may experience side effects. Common side effects include headache, fatigue, dizziness, and nausea. Some individuals may also experience sleep disturbances or mild gastrointestinal discomfort. In rare cases, more serious side effects such as lactic acidosis or liver-related complications may occur. Regular follow-up and monitoring help in early detection and management of any adverse effects.

Entecavir should be used with caution in patients with impaired kidney function, as dose adjustments may be required. It is not recommended for individuals with known hypersensitivity to the drug. Special care is needed in patients co-infected with HIV, as inappropriate use may lead to HIV resistance if not part of a complete antiretroviral regimen. The use of entecavir during pregnancy or breastfeeding should be discussed with a healthcare provider. Regular monitoring of liver function and viral load is essential during treatment.

Entecavir has become a cornerstone in the management of chronic hepatitis B, offering potent antiviral activity and a favorable safety profile. Its ability to effectively suppress viral replication helps reduce liver damage and improve long-term outcomes. However, consistent adherence and regular monitoring are crucial for achieving the best results. With proper medical guidance, entecavir plays a vital role in controlling hepatitis B and maintaining liver health.

Entecavir is used to treat chronic hepatitis B infection by reducing the amount of virus in the body and protecting liver health.

It works by blocking the hepatitis B virus DNA polymerase enzyme, preventing the virus from replicating.

It is taken orally once daily on an empty stomach, as prescribed by a doctor.

Common side effects include headache, fatigue, dizziness, nausea, and mild digestive discomfort. These are usually manageable with proper care.

No, entecavir does not cure hepatitis B, but it helps control the virus and prevent liver damage when taken regularly.

Yes, most side effects can be managed with supportive care and regular monitoring by a healthcare provider.

Yes, many patients require long-term or lifelong treatment to maintain viral suppression and prevent disease progression.

Patients with hypersensitivity to the drug or certain medical conditions should use it only under medical supervision.